BRKR
Bruker Corporation
BRKR lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
BRKR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Healthy | |
| Weak |
BRKR's cash flow is currently healthy, and its revenue is stable, but its profitability and balance sheet are under pressure.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
BRKR PE Valuation
BRKR has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
BRKR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect BRKR's earnings to grow and its profitability to improve, with its revenue holding steady.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
BRKR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.34 | — |
| Q3 2026 | -$1.10 | -$0.94 |
| Q2 2026 | -$0.70 | -235% |
| Q1 2026 | -$0.24 | -146% |
| Q4 2025 | -$0.15 | -120% |
| Q3 2022 | $1.82 | +3.4% |
| Q2 2022 | $1.80 | +17% |
| Q1 2022 | $1.85 | +40% |
| Q4 2021 | $1.81 | +77% |
BRKR lost $1.10 per share over the past year, and its loss has widened in each of the last three quarters.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
BRKR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $874M | +1.6% |
| Q2 2026 | $838.5M | +5.2% |
| Q1 2026 | $823.4M | +2.7% |
| Q4 2025 | $977.2M | -0.2% |
| Q3 2025 | $860.5M | -0.5% |
| Q2 2025 | $797.4M | -0.4% |
| Q1 2025 | $801.4M | +11% |
| Q4 2024 | $979.6M | +15% |
BRKR's revenue grew through 2024 and has held roughly level since: $874M last quarter, up 1.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -10% | -4.4 points |
| Q2 2026 | -7.8% | -9.3 points |
| Q1 2026 | 1.2% | -2.7 points |
| Q4 2025 | 7.8% | +0.4 points |
| Q3 2025 | -6% | -14 points |
| Q2 2025 | 1.5% | -4.5 points |
| Q1 2025 | 4% | -5 points |
| Q4 2024 | 7.4% | -4.7 points |
BRKR's operating margin was −10% last quarter, down 4.4 points from the same quarter a year ago, near the bottom of its range since 2019.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over BRKR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over BRKR on profitability, with a higher operating margin.
BRKR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $96.7M | +$150.8M |
| Q2 2026 | -$106.2M | +$42.6M |
| Q1 2026 | $47M | +21% |
| Q4 2025 | $207.2M | +35% |
| Q3 2025 | -$54.1M | -1033% |
| Q2 2025 | -$148.8M | -$125.3M |
| Q1 2025 | $39M | +9650% |
| Q4 2024 | $153.3M | -12% |
BRKR's free cash flow has turned positive again: $245M over the past year, against −$11M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over BRKR on cash flow, with more consistent year-over-year improvement.
BRKR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +200K shares |
| 1 year | +0.5% | +700K shares |
| 3 years | -1.9% | -2.9M shares |
BRKR has 153M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $10M |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over BRKR on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
BRKR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 10.0x | High |
| Q2 2026 | 8.2x | High |
| Q1 2026 | 5.6x | High |
| Q4 2025 | 5.4x | High |
| Q3 2025 | 6.2x | High |
| Q2 2025 | 5.9x | High |
| Q1 2025 | 4.6x | High |
| Q4 2024 | 4.4x | High |
BRKR's net debt is about 10 years of its operating earnings (EBITDA), up from 6.2 years a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
BRKR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.3 | Neutral |
| Stochastic | 52.9 | Neutral |
BRKR's weekly RSI is 55 (neutral) and its Stochastic is 53 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
BRKR PE vs Healthcare Sector
| Metric | BRKR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
BRKR has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
BRKR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $59.7 | 1.1% above |
| 20 week MA | $59.1 | 2.1% above |
| 50 week MA | $50.4 | 20% above |
| 100 week MA | $46.4 | 30% above |
| 200 week MA | $58.3 | 3.6% above |
BRKR has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
BRKR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.0 | $54.3 | +6.6% |
| 2021 | $54.3 | $80.3 | +48% |
| 2022 | $80.3 | $66.5 | -17% |
| 2023 | $66.5 | $73.5 | +10% |
| 2024 | $73.5 | $58.4 | -21% |
| 2025 | $58.4 | $48.0 | -18% |
| 2026 YTD | $48.0 | $60.3 | +26% |
BRKR has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.